HepatoCellular Carcinoma Tumor Bank
Not Applicable
- Conditions
- Health Condition 1: C220- Liver cell carcinoma
- Registration Number
- CTRI/2020/02/023363
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
HCC
-PS 0 or 1 or 2
-Child pugh score A or B7
-Expected survival more than 3 month
-Willing to participate in study.
Exclusion Criteria
-Not fit for any HCC directed treatment .
-Inadequte tissue on biospy
-Not willing for biopsy and blood sampling.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The aim of the study is to better understand the biology of HCC tumors, 200 cases of HCC representing all TNM stages of the diesease will be examined. We want to understand the variability in genetic sequencing and immunohistochemistry among cohorts of HCC tissues with specific etiology, ethnicity, and stage will enable development of new therapies, prioritize therapeutic combinations, and generate patient stratification hypotheses.Timepoint: 36 Months
- Secondary Outcome Measures
Name Time Method age, gender, race, performance status, etiology of HCC, Child-Pugh score, date of pathologic diagnosis, date of death, tumor stage, pathology report, stage, grade, prior and current therapies with dates of progression, radiology reports, and HCV genotype (if appropriate).Timepoint: 36 Months